Close Menu

David Weitz and his team of Harvard University physicists are attempting to adapt microfluidics technology to sequence DNA, reports MIT's Technology Review. If they succeed, the price of sequencing a human genome could plummet to about $30. The technology, which was developed in Weitz's lab, uses picoliter droplets of water as test tubes, says Technology Review's Emily Singer. The droplets can be moved around on a microfluidics chip, injected with chemicals, and sorted based on their color.

To read the full story....

...and receive Daily News bulletins.

Already have a GenomeWeb or 360Dx account?
Login Now.

Don't have a GenomeWeb or 360Dx account?
Register for Free.

The US Food and Drug Administration is to announce stricter standards for emergency authorizations of SARS-CoV-2 vaccines, reports the Washington Post.

The Associated Press reports Johnson & Johnson is starting a late-stage clinical trial of its candidate SARS-CoV-2 vaccine.

Bloomberg reports the budget of Operation Warp Speed is actually $18 billion, higher than the number typically cited.

In Genome Research this week: genomic analysis reveals role of super-spreaders in SARS-CoV-2, epigenetic drivers of cancer, and more.